Constantinides P P, Welzel G, Ellens H, Smith P L, Sturgis S, Yiv S H, Owen A B
Drug Delivery Department, Pharmaceutical Technologies, Smith-Kline Beecham Pharmaceuticals, King of Prussia, Pennsylvania 19406, USA.
Pharm Res. 1996 Feb;13(2):210-5. doi: 10.1023/a:1016030812272.
Water-in-oil (w/o) microemulsions have been developed which, in addition to non-ionic medium-chain glycerides, incorporate ionic lipids, primarily medium-chain fatty acids, such as caprylic (C8) capric (C10) and lauric (C12) acids and their corresponding sodium salts. The absorption enhancing activity of w/o microemulsions incorporating these lipids was evaluated in the rat using Calcein (MW = 623) a water-soluble and poorly absorbed marker molecule.
Phase diagrams were constructed where C8/C10 or C12 fatty acids were treated as lipophilic surfactants and their sodium salts as hydrophilic ones. The anesthetised rat model was employed to evaluate Calcein absorption upon a single intraduodenal administration from a solution and the various w/o microemulsions.
A wide range of clear and transparent w/o microemulsions were obtained at ambient temperature either in liquid or solid form when a fixed blend of medium chain fatty acid/salt was titrated by a fixed ratio of the oil containing the oil-soluble mono- and diglycerides and deionized water or physiological saline. Upon intraduodenal administration in the anesthetised rat, the absorption of Calcein was improved from about 2% in aqueous solution up to about 37% in w/o microemulsions. Solid and liquid formulations were equally effective in improving bioavailability. The absorption enhancement activity of the fatty acids/salts followed the order C8 approximately C10 > C12. Absorption enhancement of Calcein was significantly reduced in the absence or presence of low levels of C8/C10 mono-/diglycerides.
These results further support the use of medium-chain glycerides and fatty acids/salts in microemulsion formulations to improve intestinal absorption of water-soluble compounds.
已开发出油包水(w/o)微乳剂,除了非离子中链甘油酯外,还包含离子脂质,主要是中链脂肪酸,如辛酸(C8)、癸酸(C10)和月桂酸(C12)及其相应的钠盐。使用荧光素(分子量 = 623,一种水溶性且吸收较差的标记分子)在大鼠中评估了包含这些脂质的w/o微乳剂的吸收增强活性。
构建相图,其中将C8/C10或C12脂肪酸视为亲脂性表面活性剂,其钠盐视为亲水性表面活性剂。采用麻醉大鼠模型,评估单次十二指肠内给予溶液和各种w/o微乳剂后荧光素的吸收情况。
当通过固定比例的含有油溶性单甘油酯和双甘油酯的油与去离子水或生理盐水滴定中链脂肪酸/盐的固定混合物时,在环境温度下可获得多种澄清透明的液态或固态w/o微乳剂。在麻醉大鼠十二指肠内给药后,荧光素的吸收从水溶液中的约2%提高到w/o微乳剂中的约37%。固态和液态制剂在提高生物利用度方面同样有效。脂肪酸/盐的吸收增强活性顺序为C8≈C10>C12。在不存在或存在低水平的C8/C10单甘油酯/双甘油酯时,荧光素的吸收增强显著降低。
这些结果进一步支持在微乳剂配方中使用中链甘油酯和脂肪酸/盐来改善水溶性化合物的肠道吸收。